Cas 1086627-08-8,(E)-1-(4-hydroxy-3-methyIphenyI)-3-(4-methylthiazoI-5-yl)prop-2-en-1-one

1086627-08-8

Post Buying Request

Basic information

Product Name: (E)-1-(4-hydroxy-3-methyIphenyI)-3-(4-methylthiazoI-5-yl)prop-2-en-1-one
Synonyms: (E)-1-(4-hydroxy-3-methyIphenyI)-3-(4-methylthiazoI-5-yl)prop-2-en-1-one
CAS NO:1086627-08-8
Molecular Formula:
Molecular Weight: 259.329
EINECS: N/A
Product Categories: N/A
Mol File: 1086627-08-8.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (E)-1-(4-hydroxy-3-methyIphenyI)-3-(4-methylthiazoI-5-yl)prop-2-en-1-one(CAS DataBase Reference)
NIST Chemistry Reference: (E)-1-(4-hydroxy-3-methyIphenyI)-3-(4-methylthiazoI-5-yl)prop-2-en-1-one(1086627-08-8)
EPA Substance Registry System: (E)-1-(4-hydroxy-3-methyIphenyI)-3-(4-methylthiazoI-5-yl)prop-2-en-1-one(1086627-08-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1086627-08-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1086627-08-8 Suppliers

Recommended suppliersmore

1086627-08-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1086627-08-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,6,6,2 and 7 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1086627-08:
(9*1)+(8*0)+(7*8)+(6*6)+(5*6)+(4*2)+(3*7)+(2*0)+(1*8)=168
168 % 10 = 8
So 1086627-08-8 is a valid CAS Registry Number.

1086627-08-8Upstream product

1086627-08-8Downstream Products

1086626-27-8 4-(4-hydroxy-3-methylphenyl)-6-(4-methyl-1,3-thiazol-5-yl)pyrimidin-2(1H)-one

1086627-08-8Relevant articles and documents

PYRIMIDINONES AS CASEIN KINASE II (CK2) MODULATORS

-

Page/Page column 69-70, (2009/01/20)

A compound having Formula I :or a pharmaceutically acceptable salt thereof, wherein X, R, R and R are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof. The compounds of Fomula I are inhibitors of Casein kina

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1086627-08-8